| Symbol | Name | Last Close | Mkt Cap | DailyStocks' Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
|
Vote Now! Monday’s Close |
|---|---|---|---|---|---|
| TEVA | Teva Pharmaceutical Industries Limited | $23.43 | $23.86B | N/A |
Celgene's Filing for Ozanimod Accepted for Review in US/EU
http://www.zacks.com/stock/news/426482/celgenes-filing-for-ozanimod-accepted-for-review-in-us-eu?cid=CS-ZC-FT-426482
Jun 07, 2019 - The FDA and the EMA accept Celgene's (CELG) multiple sclerosis candidate, ozanimod, for review.
0
Lilly's Emgality Gets FDA Approval for Cluster Headache
http://www.zacks.com/stock/news/425463/lillys-emgality-gets-fda-approval-for-cluster-headache?cid=CS-ZC-FT-425463
Jun 06, 2019 - Lilly's (LLY) CGRP antibody, Emgality, becomes the first and only medicine approved to treat episodic cluster headache in adults.
0
Here are the biggest analyst calls of the day: Alphabet, Big Lots, Salesforce & more
https://www.cnbc.com/2019/06/03/calls-of-the-day-alphabet-big-lots-salesforce-more.html
Jun 03, 2019 - Here are the biggest calls on Wall Street on Monday
0
TEVA: Oppenheimer ups to Outperform
http://www.briefing.com/investor/popuppages/articlepopup.aspx?articleId=UD20190603072527
Jun 03, 2019 - Oppenheimer issues rating change for TEVA
0
Biogen Reports Interim Phase III Data on Diroximel Fumarate
http://www.zacks.com/stock/news/422832/biogen-reports-interim-phase-iii-data-on-diroximel-fumarate?cid=CS-ZC-FT-422832
May 31, 2019 - Biogen (BIIB) announces new interim results from phase III EVOLVE-MS-1 study, which showed that the diroximel fumarate was generally well tolerated in people with relapsing MS.
0
Here are the biggest analyst calls of the day: Tesla, Apple, Citi, Verizon & more
https://www.cnbc.com/2019/05/30/calls-of-the-day-tesla-apple-citi-verizon-more.html
May 30, 2019 - Here are the biggest calls on Wall Street on Thursday
0
Jim Cramer: It's time to start buying amid market weakness, but take it slow
https://www.cnbc.com/2019/05/29/jim-cramer-its-time-to-start-buying-amid-market-weakness.html
May 29, 2019 - "Now that people are really freaking out ... I think it's time to start picking up stocks into weakness," Jim Cramer says.
0
Teva's Legal Overhang Triggers UBS Downgrade, Near-Halving Of Price Target
http://feeds.benzinga.com/~r/benzinga/~3/XmwzXSU6jQ4/tevas-legal-overhang-triggers-ubs-downgrade-near-halving-of-price-target
May 29, 2019 -
Teva Pharmaceutical Industries Ltd (NYSE: TEVA) shares have been under pressure since mid-May, when it was accused along with other generic companies for inflati
0
Teva: One Of My Top 5 Picks
https://seekingalpha.com/article/4267040-teva-one-top-5-picks?source=feed_tag_israel
May 29, 2019 - An honest appraisal of the situation facing Teva.A discussion of Teva's lawsuits.An estimation of Teva's normalized FCF.Why Teva today is dramatically undervalued.
0
Teva Settles With Oklahoma, Shares Fall Following Downgrade
http://www.zacks.com/stock/news/421544/teva-settles-with-oklahoma-shares-fall-following-downgrade?cid=CS-ZC-FT-421544
May 29, 2019 - Teva (TEVA) plummets after settlement with the state of Oklahoma in a litigation related to its role in opioid epidemic, resulting in a rating downgrade.
0